In a recent Reuters article, IPOX® research analyst Lukas Muehlbauer highlighted strong institutional and retail demand for Bicara Therapeutics' IPO, which raised $315 million after upsizing twice. Bicara’s shares surged 46% in its debut, driven by confidence in its lead anti-cancer drug and notable backing from TPG and Biocon.

Several major IPOs are expected, including Titan America’s $500 million U.S. listing, Samsonite’s dual U.S.-Hong Kong offering, and Midea Group’s $3 billion Hong Kong IPO, the largest in the region since 2021. Carlyle’s Acrotec Group could raise $4.7 billion in Zurich. Other notable deals include Delivery Hero’s Talabat listing in Dubai and Advanta Enterprises planning a $500 million IPO in India by 2025.

In Bloomberg, IPOX® CEO Josef Schuster discussed the resurgence of SPACs, noting $2 billion raised in August. He emphasized SPACs as a viable alternative to traditional IPOs for niche sectors, with renewed interest from sponsors. IPOX® tracks these trends as companies explore new public listing avenues.

MBX Biosciences, specializing in GLP-1 drugs, has filed for a Nasdaq IPO. Delivery Hero plans to list its MENA unit, Talabat, in Dubai with a valuation of around $5.5 billion. Tembo E-LV will go public via a $904 million SPAC deal. Duality Biotherapeutics is preparing for a Hong Kong IPO, focusing on its ADC pipeline. NMDC Energy is launching an IPO in Abu Dhabi to raise $877 million.

Yanolja's Nasdaq IPO faces delays due to liquidity issues at its subsidiary, Qoo10, potentially impacting its financial health. Swiggy, India's food delivery giant, targets a $15 billion valuation in its upcoming IPO, one of the country's largest this year. Meanwhile, Japan's Kioxia Holdings plans a $500 million IPO, anticipated to be the largest in Japan since 2018.

WeRide delays Nasdaq debut while Samsonite eyes U.S. dual listing. European fintech giant Revolut secures $45B valuation, hinting at future IPO. Asian markets see flurry of activity with Airwallex targeting 2026 listing and 99 Speed Mart launching Malaysia's largest IPO in 7 years. Chinese firms explore Hong Kong listings despite market slowdown.

Abnormal Security raised $250M for IPO prep, aiming for a 2025 listing. China Resources Beverage received approval for a $1B Hong Kong IPO, while Honor, with state backing, eyes an A-share IPO. Continental revised spin-off plans, considering a Frankfurt listing for its automotive unit. Klarna explores a secondary share sale before a potential IPO. Egypt targets $2.5B from its government IPO program in FY2024/25.

Seeking Alpha published an analysis of the First Trust US Equity Opportunities ETF (FPX), which tracks our IPOX® 100 U.S. Index. The article states that "FPX is larger, more liquid, and better diversified" than its closest competitor.

In the U.S., AI chipmaker Cerebras Systems plans an October 2024 IPO, while Chinese firms YXT.com and WeRide file for Nasdaq listings. In Europe, the London Stock Exchange denies lowering standards for Shein's potential IPO. Asia sees activity with LG CNS preparing for a Seoul IPO, Zhongmiao Holdings pricing its Hong Kong offering, and Indian e-scooter maker Ola Electric setting terms for a major IPO, attracting global investors.

In the US, Medline Industries explores a $50 billion valuation IPO, while Google's acquisition talks with IPO candidate Wiz fell through. Europe sees Dolce&Gabbana considering an IPO and UK regulators easing capital raising rules. In Asia, Chinese companies like Midea and Hozon target Hong Kong and Southeast Asian markets for IPOs. The UAE's Pathfinder secures funding for a NASDAQ listing.